Feb 17th, 2015
Starpharma is presenting to more than 200 investors at ASX Investor Series event in Sydney.
The ASX Investor Series is hosted by the ASX in conjunction with Finance News Network (FNN) and is designed to engage the investment community and bring together ASX-listed companies, investors and financial market participants.Read More
Feb 16th, 2015
Starpharma today released its interim report and financial results for the half-year ended 31 December 2014.
- Reported loss of $8.5M (Dec 2013: $5.6M)
- Cash position at 31 December 2014 of $39.3M
- R&D tax incentives of $1.6M reported in the half-year (Dec 2013: $2.6M)
- Receipt of $4.2M R&D tax incentive refund
- $20.5M net proceeds from equity placement and share purchase plan
Jan 12th, 2015
Starpharma today announced that CEO Dr Jackie Fairley will present at the 7th Annual Biotech ShowcaseTM conference in San Francisco this week. The Biotech ShowcaseTM coincides with the Annual J.P. Morgan Healthcare Conference, which Starpharma is also attending.Read More